The latest classification in the revised fifth edition of the WHO in 2022 includes entities of ALCL depending on the presence of ALK translocations, the so-called ALK-positive (ALK+) and ALK-negative (ALK−) ALCL and the breast implant-associated ALCL (BIA-ALCL) [2]. Here, ALK is linked to anaplastic large cell lymphoma.